Arca Biopharma | ABIO - Debt


Arca Biopharma reported $0 in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 54.59B 1.62B Sep/2025
Arca Biopharma USD 0 0 Mar/2025
Biogen USD 6.29B 1.7M Dec/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Cytokinetics USD 1.2B 338.79M Sep/2025
Daiichi Sankyo JPY 201.14B 99.81B Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Grifols EUR 9.23B 626.05M Dec/2024
Laboratory Of America USD 6.53B 16.1M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Otsuka Holdings JPY 211.51B 41.2B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
United Therapeutics USD 200M 100M Mar/2025